Clinical Trial Update: Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating palifermin for reducing dysphagia in locally advanced non-small cell lung cancer has completed, with results posted in 2014. The sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysphagia
• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Palifermin (palifermin)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Dysphagia, Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-03-06